Cytotoxic proteins combined with prodigiosin obtained from Serratia marcescens have both broad and selective cytotoxic activity on tumor cells

Journal of Chemotherapy

Volumn 18, Issue 2, 2006, Pages 172-181

  Abrahantes Pérez, Maria Del Carmen ^a   Reyes Gonzalez J ^a   Veliz Rios G ^a   Bequet Romero, M ^a   Gomez Riera R ^a   Anais Gasmury, C ^a   Huerta, V ^a   Gonzalez L J ^a   Canino, C ^a   Garcia, J ^a   Valdez J ^a   Reyes, B ^a   Valdes R ^a   Martinez E ^a  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

Author keywords

Anticancer; Antitumor; Cancer therapy; Cytotoxic protein; MG2327; P50; Prodigiosin; Serralisin; Serratia marcescens; Serratia marcescens CMIB4202

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOTOXIC FACTOR; DNA FRAGMENT; PRODIGIOSIN; PROTEIN P50;

APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; ELECTROPHORESIS; HEP 2 CELL; HUMAN; HUMAN CELL; NICK END LABELING; PROTEIN ANALYSIS; SERRATIA MARCESCENS; TUMOR CELL;

EID: 33646828179     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2006.18.2.172     Document Type: Article

References (35)

1. Bennett JW, Bentley R. Seeing red: the story of prodigiosin. AdV. Appl. Microbiol. 2000; 47: 1-32.
2. Manderville RA. Synthesis, proton-affinity and anti-cancer properties of the prodigiosin-group natural products. Curr. Med. Chem.-Anti-Cancer Agents 2001; 1(2): 195-218.
3. Montaner B, Perez_Tomas R. The prodigiosins: a new family of anticancer drugs. Curr Cancer Drug Targets 2003; 3(1): 57-65.
4. NCI Internet at www.dtp.nci.nih.gov, the NSC number for prodigiosin is 47147-F. 2003.
5. Maeda H, Molla A, Sakamoto K, Murakami A, Matsumura Y. Cytotoxicity of bacterial proteases in various tumor cells mediated through alpha 2-macroglobulin receptor. Cancer Res. 1989; 49(3): 660-664.
6. Wu J, Akaike T, Hayashida K, Okamoto T, Okuyama A, Maeda H. Enhanced vascular permeability in solid tumor involving peroxynitrite and matrix metalloproteinase. Jpn J Cancer Res. 2001; 92(4): 439-451.
7. Marty KB, Williams CL, Guynn LJ, Benedik MJ, Blanke SR. Characterization of a cytotoxic factor in culture filtrates of Serratia marcescens. Infect Immun 2002; 70(3): 1121-1128.
8. Carbonell GV, Amorim CR, Furumura MT, Darini AL, Fonseca BA, Yano T. Biological activity of Serratia marcescens cytotoxin. Braz J Med Biol Res. 2003; 36(3): 351-359.
9. Carbonell GV, Falcon R, Yamada AT, da Fonseca BA, Yano T. Morphological and intracellular alterations induced by Serratia marcescens cytotoxin. Res Microbiol. 2004; 155(1): 25-30.
10. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 1983; 65(1-2): 55-63.
11. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. Plainview, N.Y.: Cold Spring Harbor Laboratory Press 1989.
12. Skehan P, Storeng R, Scudiero D et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 1990; 82(13): 1107-1112.
13. Soldatenkov VA, Prasad S, Voloshin Y, Dritschilo A. Sodium butyrate induces apoptosis and accumulation of ubiquitinated proteins in human breast carcinoma cells. Cell Death Differ. 1998; 5(4): 307-312.
14. Apoptosis Detection System, Fluorescein, Technical Bulletin #TB235, Promega Corporation.
15. Hardy E. "Reverse-staining" of biomolecules in electrophoresis gels: analytical and micropreparative applications. Anal Biochem. 2004; 328(1): 1-13.
16. Bairoch A, Apweiler R. The SWISS-PROT protein sequence data bank and its new supplement TREMBL. Nucleic Acids Res. 1996; 24(1): 21-25.
17. Pearson WR, Lipman DJ. Improved tools for biological sequence comparison. Proc Natl Acad Sci USA. 1988; 85(8): 2444-2448.
18. Zor T, Selinger Z. Linearization of the Bradford protein assay increases its sensitivity: theoretical and experimental studies. Anal Biochem. 1996; 236(2): 302-308.
19. Williams RP, Gott CL, Qadri SM. Induction of pigmentation in nonproliferating cells of Serratia marcescens by addition of single amino acids. J Bacteriol. 1971; 106(2): 444-448.
20. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5269): 680-685.
21. Klose J, Kobalz U. Two-dimensional electrophoresis of proteins: An updated protocol and implications for a functional analysis of the genome. Electrophoresis 1995; 16(6): 1034-1059.
22. Giri AV, Anandkumar N, Muthukumaran G, Pennathur G. A novel medium for the enhanced cell growth and production of prodigiosin from Serratia marcescens isolated from soil. BMC Microbiol. 2004; 4: 11.
23. Braunage SC, Benedik MJ. The metalloprotease gene of Serratia marcescens strain SM6. Mol Gen Genet. 1990; 222(2-3): 446-451.
24. Nakahama K, Yoshimura K, Marumoto R et al. Matsubara H. Cloning and sequencing of Serratia protease gene. Nucleic Acids Res. 1986; 14(14): 5843-5854.
25. Finlay BB, Falkow S. Common themes in microbial pathogenicity. Microbiol Rev. 1989; 53(2): 210-230. Review.
26. Chakrabarty AM. Microorganisms and cancer: quest for a therapy. J Bacteriol. 2003; 185(9): 2683-2686. Review.
27. Kobayashi N, Ichikawa Y. Separation of the prodigiosin-localizing crude vesicles which retain the activity of protease and nuclease in Serratia marcescens. Microbiol Immunol. 1991; 35(8): 607-614.
28. Escobar MM, Carbonell GV, Beriam LOS, Siquiera WJ, Yano T. Cytotoxin production in phytopathogenic and entomopathogenic Serratia marcescens. Rev Latinoam. Microbiol. 2001; 43(4): 165-170.
29. Ronen D, Schwartz D, Teitz Y, Goldfinger N, Rotter V. Induction of HL-60 cells to undergo apoptosis is determined by high levels of wild-type p53 protein whereas differentiation of the cells is mediated by lower p53 levels. Cell Growth Differ. 1996; 7(1): 21-30.
30. Montaner B, Pérez-Tomás R. Prodigiosin-induced apoptosis in human colon cancer cells. Life Sci. 2001; 68(17): 2025-2036.
31. Hamada K, Hata Y, Katsuya Y, Hiramatsu H, Fujiwara T, Katsube Y. Crystal structure of Serratia protease, a zinc-dependent proteinase from Serratia sp. E-15, containing a beta-sheet coil motif at 2.0 A resolution. J Biochem. (Tokyo) 1996; 119(5): 5844-5851.
32. B. Montaner, S. Navarro, M. Pique et al. Prodigiosin from the supernatant of Serratia marcescens induces apoptosis in haematopoietic cancer cell lines. Br J Pharmacol. 2000; 131(3): 585-593.
33. Carbonell GV, Alfieri AF, Alfieri AA et al. Detection of cytotoxic activity on Vero cells in clinical isolates of Serratia marcescens. Braz J Med Biol Res. 1997; 30(11): 1291-1298.
34. Carbonell GV, Della Colleta HH, Yano T, Darini AL, Levy CE, Fonseca BA. Clinical relevance and virulence factors of pigmented Serratia marcescens. FEMS Immunol Med Microbiol. 2000; 28(2): 143-149.
35. Viñas M, Lorén JG, Guinea J. Particulate-bound pigment of Serratia marcescens and its association with the cellular envelopes. Microbios Lett 1983; 24: 19-26.